Relmada Therapeutics, Inc Alternatives & Competitors
12 companies similar to Relmada Therapeutics, Inc — Relmada (Nasdaq: $RLMD) is a clinical-stage company developing novel therapies f...
Companies similar to Relmada Therapeutics, Inc
Vistagen
Changing the trajectory of mental health care – One Mind at a Time
South San Francisco, Unit...
Emalex Biosciences
Improving people's lives impacted by central nervous system disorders through meaningful s...
Chicago, United States
Cybin Inc
We’re on a mission to revolutionize mental healthcare
Toronto, Canada
Cavion
Empowering therapies for cancer and neurologic diseases through pioneering ion channel inh...
Rival Readout
Competing with Relmada Therapeutics, Inc? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Chance Pharmaceuticals 畅溪制药
A clinical-stage biotech company focusing on discovering, developing and commercializing i...
China
Reviva Pharmaceuticals
Next Generation Therapeutics to successfully address central nervous system, metabolic and...
Cupertino, United States
Euthymics Bioscience
Developing next-gen treatments for depression targeting those unmet by SSRIs
Longboard Pharmaceuticals
We Are Committed To Transforming the Lives of Patients With Neurological and Rare Diseases...
La Jolla, United States
Seelos Therapeutics, Inc.
A clinical-stage biopharmaceutical company focused on central nervous system disorders and...
New York, United States
Cerevance
Cerevance a neuroscience company
Boston, United States
Praxis Precision Medicines, Inc.
The era of genetic neuroscience has arrived
Boston, United States
Acadia Pharmaceuticals
Acadia is trailblazing breakthroughs in neuroscience to elevate life.
San Diego, United States
About Relmada Therapeutics, Inc
Relmada Therapeutics, Inc is a clinical-stage company with a focus on developing innovative therapies for diseases of the central nervous system (CNS), particularly major depressive disorder (MDD). Their lead program, REL-1017, a novel NMDA receptor channel blocker, is currently in late-stage development for the treatm...
Clinical-stage Therapies, Central Nervous System Diseases, CNS Drug Development, NMDA Receptor Targeting, Major Depressive Disorder, Neurodegenerative Diseases, Late-stage Development, Pharmaceutical Research, Adjunctive Treatment, Monotherapy, Psychiatric Disorders, Mental Health Therapies
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around Relmada Therapeutics, Inc: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at Relmada Therapeutics, Inc on 3 Dec 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
